Board of Directors
With over 30 years of experience in the specialty pharmacy industry, Jeff Rowe most recently served as Executive Vice President and board member of Diplomat Inc., the largest independent specialty pharmacy company in the United States. During his tenure with Diplomat, the company grew from a single location with less than US$5 million in revenue, to 16 locations and US$3 billion in sales, and became publicly traded on the New York Stock Exchange. Prior to that, Jeff owned two successful community pharmacies in Genesee County, Michigan.
An authority in pharmaceutical operations, Jeff offers critical insights into fundamental business strategies involving accreditation, contracting, cybersecurity and regulation, combined with an expertise in compounding and integrative medicine. He is uniquely qualified to identify process improvements and efficiencies while maintaining compliance and quality standards, for increased revenue, profitability and customer satisfaction. Jeff holds a Bachelor of Pharmacy degree from Ferris State University and has completed many health-related credential courses.
Johnny D. PowersExecutive Member
Dr. Powers has more than 30 years of experience leading business strategy, operations, sales and marketing, and product development in the human and pet medical diagnostics markets. Notably, he held executive roles at animal health industry leader IDEXX Laboratories, Inc. (IDEXX), where, prior to his retirement, he served as executive vice president responsible for business performance, product innovation and commercial effectiveness across multiple point-of-care and reference laboratory businesses. Currently, Powers is the president and founder of JD Powers Consulting Group, which provides strategic and executive advisory services in the healthcare industry. Dr. Powers holds a bachelor's degree in chemistry from Wake Forest University, an M.S. in chemical engineering from Clemson University, an M.B.A. from the Duke University Fuqua School of Business and a Ph.D. in biochemical engineering from North Carolina State University.
Dr. Johnny D. Powers will provide day-to-day strategic oversight and management guidance to the Zomedica team. Dr. Powers has extensive animal healthcare industry experience, most recently with IDEXX Laboratories where he was Executive Vice President with responsibility for product pipeline and commercialization across multiple business units. Over his career, Dr. Powers has overseen the development and commercialization of hundreds of diagnostic platforms and assays across the pet and human healthcare industries. In his new role, he will work closely with the executive leadership team with a primary focus on driving our new products into commercialization.
Robert CohenExecutive Member
Mr. Cohen joined Zomedica in June of 2020 following successfully serving as President and Chief Executive Officer at a series of early stage medical device and biotechnology companies. Prior to his 20 years in the CEO position, he was a member of senior management at large multinationals including St. Jude Medical, Inc., Sulzermedica, and Pfizer Inc.
Christopher WolfenbergIndependent Member
Chris Wolfenberg is a partner with Fasken Martineau DuMoulin LLP. He has practiced business law for almost 20 years and has acted as a director and officer of public, private and not for profit corporations. Chris holds an LL.M. from Cornell Law School, an LL.B. from Queen’s University and a Bachelor of Social Sciences from the University of Ottawa. He has been awarded recognition for his career in law and his community service.
Mr. Wolfenberg is a leading business lawyer in Calgary, Canada focused on public and private securities transactions in the technology, energy and mining industries. Named by Acritas as a "Star Lawyer," he acts as a Director and Officer of a number of public, private, and not-for-profit entities.
Chris MacLeodIndependent Member
Outside his work at Cambridge, Mr. MacLeod is the National Chair of the Canadian Cystic Fibrosis Treatment Society (CCFTS). The Society’s purpose is to advocate across sectors (government, charitable, insurance and pharma) for access to innovative life sustaining medication.
Additional corporate involvement includes sitting as Independent Director of Body and Mind (BAMM), a Nevada based Cannabis company listed on the CSX, serving as director of Pascal Financial Inc., a FINTECH company that provides a software solution for investment advisors and portfolio managers, and his commitment as corporate advisor to Citzn Inc. a social media start-up company.
Rodney J. WilliamsIndependent Member
With over 20 years of medical technology and related healthcare experience, Rodney (Rod) Williams has demonstrated incredible agility and success in leading both large and small cap companies through growth cycles, while strengthening their product portfolio and boosting commercial planning competencies. He is currently the Global Vice President of Portfolio and Services with Align Technology, Inc., which designs and manufactures products for dental professionals, including the Invisalign® system. Prior to Align Technology, he was an entrepreneur-in-residence with the private equity investment firm PTV Healthcare Capital and before that was president and CEO of Heart Rhythm Society Consulting Services. He also served in senior executive positions with St. Jude Medical, GE Healthcare, Johnson and Johnson, and Bausch & Lomb.
Rod earned both his MBA and Bachelor of Science degrees from the University of Southern California (USC) and attended the General Management Executive Leadership Program at The Wharton School of Business. While at USC, on football scholarship, he gained NCAA Academic All-American honors and numerous academic awards as the TOP student-athlete. Rod was drafted into the National Football League in 1985.